Insurance
Home›Insurance›Health Insurance›Survey finds GLP-1 users face retirement tradeoffs
Survey finds GLP-1 users face retirement tradeoffs
Among current GLP-1 users, 51% worry they may have to choose between paying for medication and saving enough for retirement, and those not fully covered pay an average of $203 per month out of pocket.
Optimism about living longer on GLP-1 medications is arriving faster than financial planning, according to a survey published by the Nationwide Retirement Institute.
Health optimism is linked to reduced retirement urgency, as 51% of current GLP-1 users say they worry they may have to choose between paying for their medication and saving enough for retirement.
Nearly a quarter of current users also say maintaining access to their medication already takes priority over increasing retirement savings.
The research, conducted by The Harris Poll among 1,933 US adults surveyed July 20 to August 4, found that 54% of current users have changed financial behaviors to afford their medication, including taking on debt (17%), withdrawing money from savings or retirement accounts (14%), or reducing retirement contributions (14%).
For users whose coverage does not fully cover GLP-1 costs, the survey reports an average of $203 per month in out-of-pocket expenses.